<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJU</journal-id><journal-title-group><journal-title>Open Journal of Urology</journal-title></journal-title-group><issn pub-type="epub">2160-5440</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oju.2024.141002</article-id><article-id pub-id-type="publisher-id">OJU-130578</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Upper Tract Treatment of Urogenital Fistulas at the National Fistula Treatment Center (CNTF)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahamat</surname><given-names>Ali Mahamat</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vadandi</surname><given-names>Valentin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aché</surname><given-names>Haroun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Saleh</surname><given-names>Nedjim</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abderassoul</surname><given-names>Abdraman Gadam</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kimassoum</surname><given-names>Rimtebaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Faculty of Health Sciences, University of Adam Barka, Abeche, Chad</addr-line></aff><aff id="aff3"><addr-line>University Hospital of National Reference, N’Djamena, Chad</addr-line></aff><aff id="aff1"><addr-line>Faculty of Health Sciences, University of N’Djamena, N’Djamena, Chad</addr-line></aff><pub-date pub-type="epub"><day>18</day><month>01</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>11</fpage><lpage>19</lpage><history><date date-type="received"><day>18,</day>	<month>November</month>	<year>2023</year></date><date date-type="rev-recd"><day>16,</day>	<month>January</month>	<year>2024</year>	</date><date date-type="accepted"><day>19,</day>	<month>January</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Urogenital fistula is the existence of an abnormal pathway between a urinary organ and a genital organ. It is a public health problem because of its frequency and social aspect. The aim of this study was to analyse the management of urogenital fistulas by the upper route at the National Fistula Treatment Centre in N’Djamena. 
  Material and Methods: This was a 10-year retrospective descriptive and analytical study from May 2011 to April 2021. The records of all patients who had received fistula treatment during this period were identified and analysed. 
  Results: During the study period 2369 patients were managed for cure of urogenital fistula including 84 by the upper route, i.e. 3.5%. The mean age was 28.5 &#177; 8.13 years. Loss of urine was the most common reason for consultation (71.4%). Primigravida were represented in 50% (n = 42). The average gestational age was 3.2 &#177; 2.8 with extremes of 0 to 9 pregnancies. Obstetric aetiology was the most common (92.8%). Ureterovaginal fistulas were the most common anatomoclinical type (36.9%). Uretero-vesical reimplantation was the main surgical procedure (41.7%). Late postoperative follow-up was successful in 85.7% of cases. 
  Conclusion: Urogenital fistulas are common in our practice. The only way to combat this scourge is through prevention through information, education and communication.
 
</p></abstract><kwd-group><kwd>Urogenital Fistula</kwd><kwd> Upper Tract</kwd><kwd> CNTF</kwd><kwd> N’Djamena</kwd><kwd> Chad</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Urogenital fistula (UGF) is an abnormally acquired communication between the urinary and genital tracts [<xref ref-type="bibr" rid="scirp.130578-ref1">1</xref>] . Its incidence is declining in developed countries thanks to advances in surgery and obstetrics [<xref ref-type="bibr" rid="scirp.130578-ref2">2</xref>] , where iatrogenic lesions are the main etiology [<xref ref-type="bibr" rid="scirp.130578-ref3">3</xref>] . In Africa, it remains a public health problem [<xref ref-type="bibr" rid="scirp.130578-ref4">4</xref>] , with obstetric causes the main etiology [<xref ref-type="bibr" rid="scirp.130578-ref5">5</xref>] . FUGs have medical, economic and psychosocial repercussions. Advances in surgery and obstetrics have reduced the incidence of urogenital fistulas in developed countries [<xref ref-type="bibr" rid="scirp.130578-ref2">2</xref>] . FUGs due to obstetric causes are generally complex, associated with cervical or urethral destruction compromising the sphincter apparatus and requiring specific surgical techniques [<xref ref-type="bibr" rid="scirp.130578-ref2">2</xref>] . The treatment of urogenital fistulas is a problem that has confronted urologists since the 19th century [<xref ref-type="bibr" rid="scirp.130578-ref2">2</xref>] . Surgical treatment via transvesical, retroperitoneal and transperitoneal routes remains the most indicated method for vesico-uterine, trigono-vaginal and uretero-vaginal fistulas, with high success rates [<xref ref-type="bibr" rid="scirp.130578-ref6">6</xref>] .</p><p>The choice of treatment route depends primarily on the characteristics of the fistula and partly on the operator’s experience [<xref ref-type="bibr" rid="scirp.130578-ref6">6</xref>] . The aim of this work is to report on the results of surgical treatment of fistulas by the upper route, while describing the epidemiological and etiological characteristics of urogenital fistulas at the National Fistula Treatment Center.</p></sec><sec id="s2"><title>2. Methodology</title><p>This was a retrospective, descriptive and analytical study carried out at the National Fistula Treatment Center over the period from May 2011 to April 2021. All women with urogenital fistulas who had undergone fistula repair surgery via the upper approach and whose medical records were complete were included in the study. Women with non-urogenital fistulas, who were treated at another health facility and/or had incomplete medical records were excluded from the study. Data were collected from patient records, operating room registers, the CNTF database and pre-established survey forms to collect all the information relevant to this study. These survey forms noted the variables studied, which were of a socio-demographic and clinical nature: In this study, we used the DE M CAMEY classification system, which is based on the following criteria: reason for consultation, circumstances of occurrence, etiologies of the fistula, history, duration of fistula, type of FUG, lesions associated with FUG, method of diagnosis and outcome. For this study, we used the DE M. CAMEY classification. Our results will be classified as good (when micturition was normal with no urine leakage), intermediate (when stress incontinence or nocturnal urine leakage persisted) and failure (when urine leakage was permanent). Data were analyzed using SPSS 18.0 software. The Chi<sup>2</sup> statistical test was used to compare the relationship between variables, with a significance level of p &lt; 0.05. For ethical and deontological considerations, we obtained research authorization.</p></sec><sec id="s3"><title>3. Results</title><p>During the study period, 2369 patients were treated for urogenital fistulas, including 84 by the upper route, representing a hospital frequency of 3.5%. The mean age was 28.5 &#177; 8.13 years, with extremes of 10 and 60 years. The most common age group was 21 - 30. (<xref ref-type="table" rid="table1">Table 1</xref>)</p><sec id="s3_1"><title>3.1. Circumstances of Occurrence (Aetiology)</title><p>Obstetric aetiology accounted for 92.8%, or n = 78.</p><sec id="s3_1_1"><title>3.1.1. Reasons for Admission</title><p>Loss of urine was found in 71.4% (n = 60). faecal losses 2.4% (n = 2), cyclic haematuria 26.2% (n = 16).</p></sec><sec id="s3_1_2"><title>3.1.2. Management Time</title><p>The time taken for treatment after 6 months was 85.7% (n = 72) and 14.3% (n = 12) before 6 months.</p><p>The average number of treatments was 3.85 &#177; 4.91, with extremes of 2 and 5. 45.2% of our patients had a history of low approach fistula cure.</p></sec></sec><sec id="s3_2"><title>3.2. Clinical Aspects</title><sec id="s3_2_1"><title>3.2.1. Examination of the Vulva and Perineum</title><p>Soft tissue represented 51.2% (n = 43) followed by excision 35.7% (n = 30).</p></sec><sec id="s3_2_2"><title>3.2.2. Methylene Blue Test</title><p>The methylene blue test was positive in 63.1% (n = 53).</p><p>Fistula size of 3 to 4 cm accounted for 54.8%. The mean size of the fistula was 2.90 cm &#177; 1.49 with extremes of 1 to 7 cm.</p></sec><sec id="s3_2_3"><title>3.2.3. Paraclinical Data</title><p>1) Biological examination</p><p>a) Creatininaemia</p><p>Creatinine levels were measured in all patients, 82 of whom had normal clearance and 2.4% (n = 2) had renal failure.</p><p>b) Urine cytobacteriological examination (UCE)</p><p>A urine cytobacteriological examination was carried out on all our patients. This revealed three cases of urinary tract infection, including two cases of Escherichia coli and one case of Klebsiella pneumonia.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> R&#233;partition des patients selon les &#233;tiologies FUG</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Etiology</th><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="4"  >Obstetrics</td><td align="center" valign="middle" >Caesarean section</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >27.5</td></tr><tr><td align="center" valign="middle" >Hysterectomy</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >14.2</td></tr><tr><td align="center" valign="middle" >RU laparotomy</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >13.1</td></tr><tr><td align="center" valign="middle" >Obstructed delivery</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >38.1</td></tr><tr><td align="center" valign="middle" >Surgical</td><td align="center" valign="middle" >Urological</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5.9</td></tr><tr><td align="center" valign="middle" >Traumatic</td><td align="center" valign="middle" >Fall on the pool</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.2</td></tr></tbody></table></table-wrap><p>2) Radiological investigations</p><p>a) Pelvic ultrasound</p><p>Ultrasound was performed in 25 patients (29.8%). It showed:</p><p>- 2 cases of unilateral ureterohydronephrosis (2.4%).</p><p>- 4 cases of bladder calculi (4.8%).</p><p>b) Intravenous urography (IVU)</p><p>Intravenous urography (IVU) was performed in 35 of our patients.</p><p>It contributed to the diagnosis of 33 cases of fistula:</p><p>- 31 cases of UVF (ureterovaginal fistula).</p><p>- 2 cases of VVF (vesico-vaginal fistulas).</p><p>Hysterography was performed on 23 patients, 27.4% of whom (n = 21) had vesico-uterine fistulas.</p><p>Cystoscopy was not performed in our series.</p><p>Distribution of patients according to fistula type.</p><p>Type III fistula accounted for 70.2% (n = 59).</p><p>Ureterovaginal fistula represented 36.9% (n = 31), followed by vesico-vaginal fistula represented 35.7% (n = 30). Vesico-uterine fistula accounted for 25% (n = 21).</p></sec><sec id="s3_2_4"><title>3.2.4. Associated Lesions</title><p>In our series, we found two cases of rectovaginal fistula (2.3% (n = 2)) and 4 cases of bladder lithiasis (4.8%). The other associated lesions were mainly skin lesions such as papules containing calcareous deposits located on the labia majora.</p><p>In this series, spinal anaesthesia was used in 85.7% of cases (n = 72). General anaesthesia was used in 9.5% (n = 8). Mixed (converted) in 4.8% (n = 4). (<xref ref-type="table" rid="table2">Table 2</xref>)</p></sec></sec><sec id="s3_3"><title>3.3. Approach</title><p>In our series, 5 cases had undergone mixed route surgery, i.e. 6%, and 79 cases had undergone upper route surgery, i.e. 94%, of which 36%, i.e. 30 cases, had undergone extraperitoneal surgery and 58%, i.e. n = 49 cases, had undergone transperitoneovesical surgery.</p><sec id="s3_3_1"><title>3.3.1. Approach According to Type of Anatomical Lesion</title><p>1) Vesico-vaginal fistulas</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution according to approach</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Approach</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Mixed (low + high)</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >High: extra-peritoneal</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >36</td></tr><tr><td align="center" valign="middle" >Trans-peritoneal</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >58</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>The patients who had benefited from the mixed route cure with 5 cases, i.e. 16.66%, of which two had RVF (2.38%) and 3 type II RVF.</p><p>Among our patients treated by the upper approach (n = 25, i.e. 83.33%), we found:</p><p>- 8 cases of type I VVF, including 4 associated with bladder lithiasis;</p><p>- 17 cases of type II VVF.</p><p>2) Vesico-uterine fistulas</p><p>All vesico-uterine fistulas (21 cases) were treated by the upper approach.</p><p>3) Ureterovaginal fistulas</p><p>All ureterovaginal fistulas (31 cases) were treated by the upper approach.</p><p>4) Vesico-urethral fistulas</p><p>All the vesico-urethral fistulas (2 cases) were treated by the upper approach.</p><p>Distribution of approaches according to type of lesion:</p><p>- Vesico-vaginal fistulas were treated via the upper extraperitoneal route;</p><p>- Ureterovaginal fistulas were approached via the transperitoneal/transvesical route;</p><p>- Vesico-uterine fistulas were approached via the transvesical/extraperitoneal route;</p><p>- Trigono-vaginal fistula, the approach was transvesical. Proc&#233;d&#233; de fermeture.</p><p>The high extraperitoneal route with vesico-vaginal splitting and plane-by-plane closure was used in 35.7% (n = 30).</p><p>The upper transperitoneal route with separate closure in two planes was used in 25% (n = 21). Urethroplasty was performed in 7 cases (8.3%).</p><p>All cases of ureterovaginal fistula (33 cases or 39.3%) had undergone ureterovesical reimplantation with an anti-reflux system using the Politano-Leadbetter technique. (<xref ref-type="table" rid="table3">Table 3</xref>)</p></sec><sec id="s3_3_2"><title>3.3.2. Procedures Performed</title><p>Uretero-vesical reimplantation was reported in 41.7% (n = 35).</p></sec><sec id="s3_3_3"><title>3.3.3. Associated Procedures</title><p>Urethral plasty was associated in 7 cases (8.3%). Cystolithotomy was 4.8% (n = 4), recto-vaginal fistula (RVF) 2.4% (n = 2).</p></sec><sec id="s3_3_4"><title>3.3.4. Type of Catheter</title><p>Urethrovesical catheters were used in 51 patients (60.7%), followed by 33 ureteral catheters (29.3%).</p><p>Upper extra-peritoneal route (VHEP).</p></sec><sec id="s3_3_5"><title>3.3.5. Duration of Catheter Use</title><p>The average length of time the catheter was worn was 15.04 days &#177; 8.8 with extremes of 10 days and 92 days.</p><p>The urethrovesical catheter was worn for 15 days in 40 patients (47.6%). The ureteral catheter represented 20 cases or 23.3%.</p></sec><sec id="s3_3_6"><title>3.3.6. Length of Hospital Stay</title><p>The average length of hospitalisation was 16.7 days &#177; 10.9 days, with extremes of 10 and 42 days. Hospital stays of 15 to 21 days accounted for 75% of cases.</p></sec><sec id="s3_3_7"><title>3.3.7. Post-Operative Follow-Up</title><p>Following the operation, there were:</p><p>- 8 cases (9.5%) of stress urinary incontinence. These were urethro-cervico-vaginal fistulas (type II).</p><p>- 2 cases (2.4) of parietal suppuration and 2 cases (2.4) of vesico-cutaneous fistula.</p></sec><sec id="s3_3_8"><title>3.3.8. Overall Results</title><p>Of all the fistulas operated on, we recorded: 72 cases of success, i.e. a rate of 85.7%, including, 4 intermediate results, i.e. 4.8% and 8 failures, i.e. 9.5% of patients. (<xref ref-type="table" rid="table4">Table 4</xref>)</p><p>Vesico-uterine fistulas were successfully treated in 90.5% of patients.</p></sec></sec><sec id="s3_4"><title>3.4. Results of Associated Treatment</title><p>Two cases of recto-vaginal fistula, 4 cases of cystolithotomy and 7 cases of uretero-vesical reimplantation were successfully treated.</p><p>Outcome according to previous history.</p><p>Patients with a history of fistula repair had a 79% success rate (n = 30).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Obstetric aetiology was most frequently reported at 92.9%. This result is close to that of Kpatcha [<xref ref-type="bibr" rid="scirp.130578-ref7">7</xref>] in Togo in 2020, which found 95%, and higher than that of Fasnewind&#233; A [<xref ref-type="bibr" rid="scirp.130578-ref8">8</xref>] in Burkina Faso in 2020, which found 81.7%. This high percentage is a reliable indicator of the inadequacies of our country’s health system, inadequacies characteristic of our underdeveloped countries. This figure also</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of patients according to anatomo-clinical type and closure procedure</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Types of FUG</th><th align="center" valign="middle" >Procedure</th><th align="center" valign="middle" >Success</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >FUV</td><td align="center" valign="middle" >- Uretero-vesical reimplantation</td><td align="center" valign="middle" >28/33</td><td align="center" valign="middle" >84.8</td></tr><tr><td align="center" valign="middle" >FVV</td><td align="center" valign="middle" >- VHEP with VV duplication</td><td align="center" valign="middle" >26/29</td><td align="center" valign="middle" >86.6</td></tr><tr><td align="center" valign="middle" >FVU</td><td align="center" valign="middle" >- VHEP with VU duplication</td><td align="center" valign="middle" >18/20</td><td align="center" valign="middle" >90</td></tr></tbody></table></table-wrap><p>Ureterovaginal fistula (UVF); Vesico-vaginal fistula (VVF); Utero-vaginal fistula (UVF).</p><p>indicates that the efforts made in recent years by our countries to reduce perinatal morbidity are insufficient.</p><p>In this series, 45.2% of patients underwent surgery once. This result is higher than that of Lamine N [<xref ref-type="bibr" rid="scirp.130578-ref9">9</xref>] in Guinea Biseau in 2016, who found 27.9%. This can be explained by the fact that in this series of studies, our patients were operated on several times, i.e. at least once before coming to the specialist centre. These multiple cures were sufficient proof of the complexity of fistula surgery, which must take into account the location of the fistula, the quality of the tissue, the size and experience of the repairer.</p><p>In terms of classification, type III fistulas dominate with a rate of 70.2%. This result is higher than those obtained by Vadandi [<xref ref-type="bibr" rid="scirp.130578-ref10">10</xref>] in Chad in 2019 and Kimassoum [<xref ref-type="bibr" rid="scirp.130578-ref11">11</xref>] in Chad in 2016, which obtained 54% and 40.5% respectively. This difference can be explained by the size of the sample and the long duration of the year (10 years).</p><p>Regarding the types of fistula, ureterovaginal fistulas are the most common anatomo-clinical aspect with a rate of 36.9%. This rate is higher than those of Sanda G [<xref ref-type="bibr" rid="scirp.130578-ref6">6</xref>] in Niger in 2016 and Konan P [<xref ref-type="bibr" rid="scirp.130578-ref12">12</xref>] in C&#244;te d’Ivoire in 2015, who found a rate of 22.5% and 11.43% respectively. This difference could be explained by the fact that the study focused solely on upper urogenital fistulas, unlike some authors who have conducted their studies on urogenital fistula globally, where certain anatomo-clinical types predominate over ureterovaginal fistulas.</p><p>Locally, the tissue surrounding the fistula, in particular the vagina and perineum, were soft in 54.8% of cases. This rate is lower than that found by Sanda G [<xref ref-type="bibr" rid="scirp.130578-ref6">6</xref>] in Niger in 2016 who reported 75% soft tissue. The predominance of soft tissue could be explained by the fact that the vast majority of our patients had never benefited from a previous cure, as failure deteriorates the local tissue and leads to fibrosis.</p><p>As far as anaesthesia is concerned, spinal anaesthesia is the most commonly used type of anaesthesia, with a proportion of 85.7%. This result is superimposed on the data in the literature [<xref ref-type="bibr" rid="scirp.130578-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.130578-ref13">13</xref>] which reports 85.2% to 87%. Apart from contraindications, locoregional anaesthesia is the preferred technique because it involves fewer risks for patients.</p><p>Therapeutically, uretero-vesical re-implantation was the most common technique used in 39.3% of cases. This rate is lower than that of Fofana A [<xref ref-type="bibr" rid="scirp.130578-ref14">14</xref>] in C&#244;te d’Ivoire in 2021, which found 64.7%, but higher than that of Sanda G [<xref ref-type="bibr" rid="scirp.130578-ref6">6</xref>] in Niger in 2016, which found 9.6%. This can be explained by the fact that in our series, ureterovaginal fistula, which is the anatomo-clinical type most represented in our series, is repaired by ureterovesical reimplantation using the upper route.</p><p>The duration of urethrovesical catheter use was 15 days in 40 patients (47.6%). This result is in line with the literature [<xref ref-type="bibr" rid="scirp.130578-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.130578-ref10">10</xref>] .</p><p>Regarding the duration of hospitalization, 75% had a hospital stay of 16 days. Komanda L [<xref ref-type="bibr" rid="scirp.130578-ref15">15</xref>] in the DRC in 2014 reported a hospital stay of between 14 and 19 days.</p><p>Regarding the outcome, the success rate of late surgery in this series was 85.7%. This result is within the range of those reported by Kpatcha [<xref ref-type="bibr" rid="scirp.130578-ref7">7</xref>] and Diallo A [<xref ref-type="bibr" rid="scirp.130578-ref16">16</xref>] , which were 78.17% and 91.8%. This could be explained on the one hand by the high or mixed approach which allows good exposure of the fistula and also good closure of the fistula, and on the other hand by the selection of fistulas which are high up, far from the continence system.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Urogenital fistulas are a real public health problem in our countries. Women who suffer from it are subject to all forms of social exclusion. Repairing the fistula allows these women to regain their dignity. The only way to combat this scourge is through prevention through information, education and communication.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare that they have no conflict of interest.</p></sec><sec id="s7"><title>Cite this paper</title><p>Mahamat, M.A., Valentin, V., Haroun, A., Nedjim, S., Gadam, A.A. and Rimtebaye, K. (2024) Upper Tract Treatment of Urogenital Fistulas at the National Fistula Treatment Center (CNTF). Open Journal of Urology, 14, 11-19. https://doi.org/10.4236/oju.2024.141002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.130578-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Hilton, P. (2003) Vesico-Vaginal Fistulas in Developing Countries. International Journal of Gynecology &amp; Obstetrics, 82, 285-295. https://doi.org/10.1016/S0020-7292(03)00222-4</mixed-citation></ref><ref id="scirp.130578-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Huang, W., Zinmam, L.N. and Bihile, W. (2002) Surgical Repair of Vesico-Vaginal Fistulas. Urologic Clinics of North America, 29, 709-723. https://doi.org/10.1016/S0094-0143(02)00064-2</mixed-citation></ref><ref id="scirp.130578-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Langkilde, N.C., Pless, T.K., Lundbeck, F. and Nerstrom, B. (1999) Surgical Repair of Vesicovaginal Fistulae: A Ten-Year Retrospective Study. Scandinavian Journal of Urology and Nephrology, 33, 100-103. https://doi.org/10.1080/003655999750016069</mixed-citation></ref><ref id="scirp.130578-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Hillary, C.J. and Chapple, C.R. (2018) The Choice of Surgical Approach in the Treatment of Vesico-Vaginal Fistulae. Asian Journal of Urology, 5, 155-159. https://doi.org/10.1016/j.ajur.2018.01.002</mixed-citation></ref><ref id="scirp.130578-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Tebeu, P.M., Fomulu, J.N., Khaddaj, S., de Bernis, L., Delvaux, T. and Rochat, C.H. (2011) Risk Factors for Obstetric Fistula: A Clinical Review. International Urogynecology Journal, 23, 387-394. https://doi.org/10.1007/s00192-011-1622-x</mixed-citation></ref><ref id="scirp.130578-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sanda, G., Chipkao, R., Harison, A., Soumana, A. and Tassiou, E.M. (2016) Les fistules urogénitales iatrogènes A propos de 62 cas et revue de la littérature. African Journal of Urology, 22, 55-60. https://doi.org/10.1016/j.afju.2015.09.007</mixed-citation></ref><ref id="scirp.130578-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kpatcha, T.M., Wangala, P., Botcho, G., Tchandana, M., Nembuzu, D., Aboubakari, A.S., et al. (2020) Profil épidémiologique, anatomocliniques et thérapeutique des fistules urogénitales et rectovaginales au Togo. Progrès en urologie, 30, 597-603. https://doi.org/10.1016/j.purol.2020.06.008</mixed-citation></ref><ref id="scirp.130578-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Fasnewindé, A., Stéphane, D., Ahmida, N., Boureima, O., Moussa, K., Adama, O., et al. (2020) Characteristics of Obstetric and Iatrogenic Urogenital Fistula in Burkina Faso: A Cross-Sectionalstudy. Advances in Urology, 6, 46-47.</mixed-citation></ref><ref id="scirp.130578-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Lamine, N., Mahamat, A., Awa, M., Oumou, M., Ndoye, M., Jalloh, M., et al. (2016) Les fistules vésico-vaginales obstétricale en Guinée-Bissau. Aspects épidémiologiques et thérapeutiques. Revue Africaine d’Urologie et d’andrologie, 8, 12-18.</mixed-citation></ref><ref id="scirp.130578-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Vadandi, V., Rimtebaye, K., Choua, O., Mahamat, A. and Tebeu, P.M. (2019) Aspects cliniques et thérapeutiques des fistules vésico-vaginales obstétricales à l’h&amp;#244;pital régional d’Abéché. Tchad. Uro Andro, 3, 11-14.</mixed-citation></ref><ref id="scirp.130578-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kimassoum, R., Franklin, D.S., Arya, Z.A.T. and Kaboro, M. (2016) Evaluation du traitement de l’incontinence urinaire après cure de fistule obstétricale. Revue Africaine d’Urologie et d’Andrologie, 1, 242 p.</mixed-citation></ref><ref id="scirp.130578-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Konan, P.G., Fofana, A., Kramo, N.F., Vodi, C.C., Gowe, E.E., Dekou, A.H., et al. (2015) les fistules urogénitales dans le service d’urologie du CHU de Cocody. Aspect évolutif de 1990-2000 et 2000-2010. Revue Africaine d’Urologie et d’andrologie, 1, 38-79.</mixed-citation></ref><ref id="scirp.130578-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, A.B., Sy, T., Bah, M.D., Diallo, T.M.O., Barry, M.S., Bah, I., et al. (2016) Fistules vésico-vaginales obstétricales en Guinée: analyse des données de trois les sites de prise en charge de l’ONG Engender Health. Progrès en urologie, 26, 145-151. https://doi.org/10.1016/j.purol.2016.01.006</mixed-citation></ref><ref id="scirp.130578-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Fofana, A., Coulibaly, N., Tuo, L., Sekou, M. and Yao, K. (2021) Les résultats du traitement chirurgical des fistules urogénitales post hystérectomies au service d’urologie du CHU de Treichville. Revue internationale des sciences d’Abidjan, 23, 114-119.</mixed-citation></ref><ref id="scirp.130578-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Komanda, L., Maindo, A.M., Lula, A. and Okenge, L. (2014) Fistules urogénitales: étude épidémiologique et clinique dans deux h&amp;#244;pitaux généraux du district de la Tshopo, Kisangani—RDC. Kismed, 5, 77-81.</mixed-citation></ref><ref id="scirp.130578-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, A., Zakou, A., Pereira, E., Jalloh, M., Ndoye, M., Niang, L., et al. (2019) Prise en charge des fistules urogénitales au service d’Urologie de l’H&amp;#244;pital Général de Grand Yoff (Dakar). Uro Andro, 2, 24-28.</mixed-citation></ref></ref-list></back></article>